Bloomberg Chinese drugmakers jumped on Monday after a local news report that a centralised drug procurement plan that is hurting drugmakers’ profit will be expanded nationwide — but on milder terms than expected. The bulk buying programme for generic drugs, which had its pilot in 11 cities last December, will be rolled out across the country with gentler rules, according ...

Bloomberg Gilead Sciences Inc agreed to pay $5.1 billion to raise its stake in Belgian biotechnology company Galapagos NV to deepen its research into inflammatory diseases and other disorders. The deal is the largest Gilead has executed since new Chief Executive Officer Dan O’Day took the reins in March as he attempts to bolster the San Francisco giant’s drug pipeline. ...

Bloomberg Finding a letter from the Church of England in his e-mail inbox was surprising enough for Vladimir Zaluzhsky, who’s in charge of investor relations at Russia’s second most valuable steelmaker. Even stranger was the demand to know what risks Severstal PJSC’s operations pose to the environment. The church’s pension board wanted details on how Severstal disposes of waste at ...